Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Non Invasive Ventilation : Efficacy of a New Ventilatory Mode in Patients With OHS

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2015 by Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Information provided by (Responsible Party):
DELRIEU Jacqueline, Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche Identifier:
First received: December 17, 2012
Last updated: July 2, 2015
Last verified: July 2015
In 2012, it has announced the availability of the new ventilator (BiPAP- A40), which could offer potential advantages over fixed level pressure support, in particular, in patients with obesity hypoventilation syndrome (OHS). One of the key benefits of the BiPAP A40 is an innovative ventilation mode called AVAPS-AE, which automatically maintains airway patency while delivering the correct level of ventilation each user requires, whatever their body position or sleep stage. AVAPS-AE mode is also aimed to help the clinicians during the initial titration of therapy, while providing long term comfort and assuring therapy compliance. However, studies on the physiologic and clinical effects have not yet been performed. The aim of our singled-blind randomised multicentre controlled trial is to prospectively investigate the effects of BiPAP with the spontaneous/timed (S/T) or the AVAPS-AE ventilation mode over 8 weeks on sleep quality, ventilation pattern, gas exchange, symptoms, body composition, level of physical activity and health-related quality of life in OHS patients.

Condition Intervention
Obesity Hypoventilation Syndrome
Device: BiPAP - A40
Device: BiPAP - ST

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Participant)
Primary Purpose: Treatment
Official Title: Clinical Benefits and Tolerance to a New Ventilatory Mode in Patients With Obesity Hypoventilation Syndrome (OHS).

Further study details as provided by Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche:

Primary Outcome Measures:
  • CHANGE IN SLEEP QUALITY [ Time Frame: Day 1 and Day 61 ]
    Sleep stage, micro arousals, apnea/hypopnea index...

Secondary Outcome Measures:
  • CHANGE IN GAZ EXCHANGE [ Time Frame: Day 1 and Day 61 ]

Other Outcome Measures:

Estimated Enrollment: 60
Study Start Date: June 2013
Estimated Study Completion Date: February 2016
Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: BiPAP - A40
BiPAP with AVAPS AE mode
Device: BiPAP - A40
Patients receiving BiPAP AVAPS - AE ventilatory mode at home
Active Comparator: BiPAP- ST
Patients receiving BiPAP- ST at home
Device: BiPAP - ST
Patients receiving BiPAP- ST mode at home.

Detailed Description:
Efficacy on sleep quality, symptoms, physical activity and quality of life

Ages Eligible for Study:   20 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Man or woman, stable patient with obesity hypoventilation syndrome, naives of non invasive ventilation.
  • PaCO2 ≥ 45 mmHg.
  • PaO2 < 70 mmHg
  • BMI ≥ 30Kg. m2

Exclusion Criteria:

  • Chronic obstructive pulmonary disease
  • Neuromuscular disease
  • Scoliosis
  • Cardiac insufficiency
  • Significant psychiatric disease
  • Sleep apnea syndrome with central apnea index > 10%
  • Treatment with benzodiazepines at the inclusion
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01757444

Contact: Jacqueline DELRIEU, Ph.D

Centre Hospitalier Universitaire d'Angers Recruiting
Angers, France
Contact: Frédéric GAGNADOUX, Pr         
Centre Hospitalier de Béziers Recruiting
Beziers, France
Contact: Frederic GOUTORBE, MD         
Hôpital Haut- Lévêque Active, not recruiting
Bordeaux, France
Centre Hospitalier de Cannes Recruiting
Cannes, France
Contact: Christophe PERRIN, MD         
Clinique du Parc Recruiting
Castelnau-le-Lez, France
Contact: Christophe BROUSSE, MD         
Hôpital du Bocage Recruiting
Dijon, France
Contact: Claudio RABEC, MD         
Hôpital Michallon Recruiting
Grenoble, France
Contact: Jean Louis PEPIN, Pr         
Hôpital Pitié-Salpêtrière Recruiting
Paris, France
Contact: Thomas SIMILOWSKI, Pr         
Hôpital La Milétrie Recruiting
Poitiers, France
Contact: Jean Claude MEURICE, Pr         
Hôpital de Bois Guillaume Recruiting
Rouen, France
Contact: Jean François MUIR, Pr   
Hôpital Larrey Active, not recruiting
Toulouse, France
Sponsors and Collaborators
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Principal Investigator: Jean-François MUIR, Pr Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
  More Information

Responsible Party: DELRIEU Jacqueline, Coordinator, Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche Identifier: NCT01757444     History of Changes
Other Study ID Numbers: 2012 - A00731 - 42
Study First Received: December 17, 2012
Last Updated: July 2, 2015

Additional relevant MeSH terms:
Obesity Hypoventilation Syndrome
Pathologic Processes
Nutrition Disorders
Body Weight
Signs and Symptoms
Respiratory Insufficiency
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Sleep Apnea, Obstructive
Sleep Apnea Syndromes
Sleep Disorders, Intrinsic
Sleep Wake Disorders
Nervous System Diseases processed this record on May 23, 2017